European Medical Solutions (EBR:ALEMS)
Belgium
· Delayed Price · Currency is EUR 4.901
-0.121 (-2.40%)
May 13, 2025, 4:20 PM CET
EBR:ALEMS Revenue
In the year 2024, European Medical Solutions had annual revenue of 47.91M EUR with 12.67% growth. European Medical Solutions had revenue of 24.71M in the half year ending December 31, 2024, with 36.80% growth.
Revenue
47.91M
Revenue Growth
+12.67%
P/S Ratio
0.43
Revenue / Employee
392.72K
Employees
122
Market Cap
20.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47.91M | 5.39M | 12.67% |
| Dec 31, 2023 | 42.53M | 5.47M | 14.76% |
| Dec 31, 2022 | 37.06M | -963.00K | -2.53% |
| Dec 31, 2021 | 38.02M | 37.66M | 10,491.90% |
| Dec 31, 2020 | 358.94K | -705.90K | -66.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.45B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 498.16M |
| Nyxoah | 4.52M |
| Onward Medical | 1.74M |
| Hyloris Pharmaceuticals | 9.76M |